JP2022531347A5 - - Google Patents
Info
- Publication number
- JP2022531347A5 JP2022531347A5 JP2021564834A JP2021564834A JP2022531347A5 JP 2022531347 A5 JP2022531347 A5 JP 2022531347A5 JP 2021564834 A JP2021564834 A JP 2021564834A JP 2021564834 A JP2021564834 A JP 2021564834A JP 2022531347 A5 JP2022531347 A5 JP 2022531347A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024000768A JP2024050582A (ja) | 2019-04-30 | 2024-01-05 | 新規のｏｍｎｉ－５０ｃｒｉｓｐｒヌクレアーゼ |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841046P | 2019-04-30 | 2019-04-30 | |
| US62/841,046 | 2019-04-30 | ||
| US201962897806P | 2019-09-09 | 2019-09-09 | |
| US62/897,806 | 2019-09-09 | ||
| US201962931630P | 2019-11-06 | 2019-11-06 | |
| US62/931,630 | 2019-11-06 | ||
| US202062959672P | 2020-01-10 | 2020-01-10 | |
| US62/959,672 | 2020-01-10 | ||
| US202062991285P | 2020-03-18 | 2020-03-18 | |
| US62/991,285 | 2020-03-18 | ||
| PCT/US2020/030782 WO2020223514A2 (en) | 2019-04-30 | 2020-04-30 | Novel omni-50 crispr nuclease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000768A Division JP2024050582A (ja) | 2019-04-30 | 2024-01-05 | 新規のｏｍｎｉ－５０ｃｒｉｓｐｒヌクレアーゼ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022531347A JP2022531347A (ja) | 2022-07-06 |
| JPWO2020223514A5 JPWO2020223514A5 (https=) | 2023-05-11 |
| JP2022531347A5 true JP2022531347A5 (https=) | 2023-05-11 |
Family
ID=73029467
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564834A Pending JP2022531347A (ja) | 2019-04-30 | 2020-04-30 | 新規のｏｍｎｉ－５０ｃｒｉｓｐｒヌクレアーゼ |
| JP2024000768A Pending JP2024050582A (ja) | 2019-04-30 | 2024-01-05 | 新規のｏｍｎｉ－５０ｃｒｉｓｐｒヌクレアーゼ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000768A Pending JP2024050582A (ja) | 2019-04-30 | 2024-01-05 | 新規のｏｍｎｉ－５０ｃｒｉｓｐｒヌクレアーゼ |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11666641B2 (https=) |
| EP (1) | EP3963061A4 (https=) |
| JP (2) | JP2022531347A (https=) |
| KR (2) | KR20250060327A (https=) |
| CN (1) | CN114127274A (https=) |
| AU (2) | AU2020266587B2 (https=) |
| BR (1) | BR112021021912A2 (https=) |
| CA (1) | CA3135759A1 (https=) |
| IL (1) | IL287693A (https=) |
| WO (1) | WO2020223514A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| EP3823633A4 (en) | 2018-06-29 | 2023-05-03 | Editas Medicine, Inc. | SYNTHETIC LEAD MOLECULES, COMPOSITIONS AND METHODS RELATED THERETO |
| US11946077B2 (en) | 2020-06-04 | 2024-04-02 | Emendobio Inc. | OMNI-59, 61, 67, 76, 79, 80, 81, and 82 CRISPR nucleases |
| WO2022098693A1 (en) * | 2020-11-04 | 2022-05-12 | Emendobio Inc. | Novel omni-50 crispr nuclease-rna complexes |
| US20240175013A1 (en) * | 2020-12-14 | 2024-05-30 | Emendobio Inc. | Biallelic knockout of trac |
| WO2022132765A1 (en) * | 2020-12-14 | 2022-06-23 | Emendobio Inc. | Biallelic knockout of b2m |
| US12091688B2 (en) | 2021-02-08 | 2024-09-17 | Emendobio Inc. | OMNI-103 CRISPR nuclease |
| KR20230142740A (ko) | 2021-02-08 | 2023-10-11 | 에멘도바이오 인코포레이티드 | Omni-103 crispr 뉴클레아제 |
| IL307855A (en) * | 2021-04-22 | 2023-12-01 | Emendobio Inc | OMNI CRISPR Nucleases 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226 , 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 and 262 news |
| IL310730A (en) * | 2021-08-12 | 2024-04-01 | Emendobio Inc | Engineered high fidelity omni-50 nuclease variants |
| JP2024540558A (ja) * | 2021-11-19 | 2024-10-31 | エメンドバイオ・インコーポレイテッド | 新規なｏｍｎｉ ｃｒｉｓｐｒヌクレアーゼ |
| US20250043260A1 (en) * | 2021-12-01 | 2025-02-06 | Emendobio Inc. | Engineered High Activity Omni-79 Nuclease Variants |
| US20260021141A1 (en) * | 2022-07-15 | 2026-01-22 | Emendobio Inc. | Strategies For Knock-Ins At APLP2 Safe Harbor Sites |
| WO2024042165A2 (en) * | 2022-08-26 | 2024-02-29 | UCB Biopharma SRL | Novel rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases |
| WO2025043140A1 (en) * | 2023-08-23 | 2025-02-27 | Emendobio Inc. | Methods and compositions for modifying expression of a mutant transforming growth factor beta induced (tgfbi) allele |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2334794B8 (en) | 2008-09-15 | 2017-04-19 | The Children's Medical Center Corporation | Modulation of bcl11a for treatment of hemoglobinopathies |
| EP3241902B1 (en) | 2012-05-25 | 2018-02-28 | The Regents of The University of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| WO2015134812A1 (en) * | 2014-03-05 | 2015-09-11 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa |
| WO2017024047A1 (en) | 2015-08-03 | 2017-02-09 | Emendobio Inc. | Compositions and methods for increasing nuclease induced recombination rate in cells |
| ES2942309T3 (es) | 2015-11-04 | 2023-05-31 | Vertex Pharma | Materiales y métodos para el tratamiento de hemoglobinopatías |
| CN105567735A (zh) * | 2016-01-05 | 2016-05-11 | 华东师范大学 | 一种凝血因子基因突变的定点修复载体系统及方法 |
-
2020
- 2020-04-30 WO PCT/US2020/030782 patent/WO2020223514A2/en not_active Ceased
- 2020-04-30 EP EP20799462.5A patent/EP3963061A4/en active Pending
- 2020-04-30 KR KR1020257013727A patent/KR20250060327A/ko active Pending
- 2020-04-30 BR BR112021021912A patent/BR112021021912A2/pt unknown
- 2020-04-30 JP JP2021564834A patent/JP2022531347A/ja active Pending
- 2020-04-30 KR KR1020217037743A patent/KR102802134B1/ko active Active
- 2020-04-30 US US17/594,761 patent/US11666641B2/en active Active
- 2020-04-30 AU AU2020266587A patent/AU2020266587B2/en active Active
- 2020-04-30 CN CN202080032631.5A patent/CN114127274A/zh active Pending
- 2020-04-30 CA CA3135759A patent/CA3135759A1/en active Pending
-
2021
- 2021-10-28 IL IL287693A patent/IL287693A/en unknown
-
2023
- 2023-04-06 US US18/296,798 patent/US20240226246A9/en active Pending
-
2024
- 2024-01-05 JP JP2024000768A patent/JP2024050582A/ja active Pending
- 2024-04-04 AU AU2024202171A patent/AU2024202171A1/en active Pending